Publication

The effectiveness of primary series CoronaVac vaccine in preventing COVID-19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May–November 2021

Mark A. Katz, Madelyn Yiseth Rojas Castro, Nabil Seyidov, M. Trent Herdman, Samir Mehdiyev, C. Jason McKnight, Alina Guseinova, Radu Cojocaru, Jason Doran, Barbara Mühlemann, Christian Drosten, Javahir Suleymanova, Richard Pebody, Esther Kissling, Gahraman Hagverdiyev

03 October 2023

Available here

Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023

Kissling Esther, Maurel Marine, Emborg Hanne-Dorthe, Whitaker Heather, McMenamin Jim, Howard Jennifer, Trebbien Ramona, Watson Conall, Findlay Beth, Pozo Francisco, Bolt Botnen Amanda, Harvey Ciaran, Rose Angela, European IVE group.

Euro Surveill. 2023;28(21):pii=2300116

Available here

Generic protocol for COVID-19 vaccine effectiveness in preventing transmission of infection in healthcare settings

Anthony Nardone, Camelia Savulescu, Esther Kissling, Marta Valenciano – Epiconcept

ECDC Stockholm: ECDC; July 2023.

Available here

Pilot protocol for influenza vaccine effectiveness against laboratory-confirmed influenza infections (symptomatic) using healthcare worker cohorts

Camelia Savulescu, Esther Kissling, Anthony Nardone (Epiconcept)

Version 1.0. Stockholm: ECDC; 2023 - 5 July 2023 - Guidance ECDC

Available here

Household transmission investigation: Design, reporting and critical appraisal

David J. Price, Violeta Spirkoska, Adrian J. Marcato, Niamh Meagher, James E. Fielding, Amalia Karahalios, Isabel Bergeri, Hannah Lewis, Marta Valenciano, Richard Pebody, Jodie McVernon, Juan-Pablo Villanueva-Cabezas.

15 June 2023

Available here

Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to SARS-CoV-2 in individuals aged 20 years and older – fourth update

Jennifer Howard, Esther Kissling, Ruoran Li, Anthony Nardone, Angie Rose (Epiconcept)

ECDC: Stockholm; 2023 March, 16

Available here

Core protocol for ECDC studies of COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection, laboratoryconfirmed with SARS-CoV-2 or with seasonal influenza – Version 2.0

Jenny Howard, Esther Kissling, Ruoran Li, Alain Moren, Anthony Nardone, Angie Rose, Marta Valenciano (Epiconcept)

Stockholm: ECDC; 2023. January

Available here

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.

Bergeri I, Whelan MG, Ware H, Subissi L, Nardone A, Lewis HC, Li Z, Ma X, Valenciano M, Cheng B, Al Ariqi L, Rashidian A, Okeibunor J, Azim T, Wijesinghe P, Le LV, Vaughan A, Pebody R, Vicari A, Yan T, Yanes-Lane M, Cao C, Clifton DA, Cheng MP, Papenburg J, Buckeridge D, Bobrovitz N, Arora RK, Van Kerkhove MD; Unity Studies Collaborator Group.

PLoS Med. 2022 Nov 10;19(11):e1004107. doi: 10.1371/journal.pmed.1004107. PMID: 36355774; PMCID: PMC9648705.

Available here

European Centre for Disease Prevention and Control. Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 20 years and older, ECDC multi-country study – third update

European Centre for Disease Prevention and Control: Sabrina Bacci, Nathalie Nicolay.
Epiconcept, Paris, France: Jennifer Howard, Esther Kissling, Anthony Nardone, Angie Rose

ECDC: Stockholm; 2022 November 8.

Available here

Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.

Savulescu C, Krizova P, Lepoutre A, Mereckiene J, Vestrheim DF, Ciruela P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Varon E, Cotter S, Winje BA, Munoz-Almagro C, Garcia L, Castilla J, Smith A, Henriques-Normark B,We  Celentano LP, Hanquet G; SpIDnet group.

Lancet Respir Med. 2017 Aug;5(8):648-656. doi: 10.1016/S2213-2600(17)30110-8. Epub 2017 Mar 27. PMID: 28359798.

Available here

Référencement Centrales d'achats

Hébergement de données de santé

Nous sommes Hébergeur de Données de Santé (HDS) à caractère personnel depuis 2012 avec la certification ISO 27001/HDS depuis 2019.

En savoir plus

Engagement et éthique

Découvrez nos engagements et valeurs dans notre charte